FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
PYTEST KIT
urea, c-14
LOE Approaching
SanofiSanofi
ORAL · CAPSULE
1997
NDA
30/100
QOLIANA
brimonidine tartrate
LOE Approaching
NovartisNovartis
OPHTHALMIC · SOLUTION/DROPS
2006
NDA
30/100
QUADRAMET
samarium sm-153 lexidronam pentasodium
LOE Approaching
Remedy Plan TherapeuticsRemedy Plan Therapeutics
INJECTION · INJECTABLE
1997
NDA
30/100
QUALAQUIN
quinine sulfate
LOE Approaching
PharmaINPharmaIN
ORAL · CAPSULE
uncomplicated Plasmodium falciparum malaria ()
2005
NDA
30/100
QUELICIN
succinylcholine chloride
LOE Approaching
PfizerPfizer
INJECTION · INJECTABLE
1953
NDA
30/100
QUELICIN PRESERVATIVE FREE
succinylcholine chloride
LOE Approaching
PfizerPfizer
INJECTION · INJECTABLE
1953
NDA
30/100
QUESTRAN
cholestyramine
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · POWDER
1973
NDA
30/100
QUESTRAN LIGHT
cholestyramine
LOE Approaching
Bristol Myers SquibbBristol Myers Squibb
ORAL · POWDER
1988
NDA
30/100
QUIDE
piperacetazine
LOE Approaching
ORAL · TABLET
1969
NDA
30/100
QUINAGLUTE
quinidine gluconate
LOE Approaching
BayerBayer
ORAL · TABLET, EXTENDED RELEASE
1969
NDA
30/100
QUINIDEX
quinidine sulfate
LOE Approaching
PfizerPfizer
ORAL · TABLET, EXTENDED RELEASE
pseudobulbar affect (PBA)
1962
NDA
30/100
QUINIDINE GLUCONATE
quinidine gluconate
LOE Approaching
Eli Lilly and CompanyEli Lilly and Company
INJECTION · INJECTABLE
1950
NDA
30/100
QUIOFIC
folic acid
Launch
ORAL · SOLUTION
2026
NDA
30/100
QUIXIN
levofloxacin
LOE Approaching
S
Santen
OPHTHALMIC · SOLUTION/DROPS
plagueincluding pneumonic+26
2000
SMNDA
30/100
R-GENE 10
arginine hydrochloride
LOE Approaching
PfizerPfizer
INJECTION · INJECTABLE
1973
NDA
30/100
RADICAVA
edaravone
Peak
Tanabe Pharma AmericaTanabe Pharma America
INTRAVENOUS · SOLUTION
2017
NDA
30/100
RADIOGARDASE (PRUSSIAN BLUE)
prussian blue insoluble capsules
LOE Approaching
ORAL · CAPSULE
2003
NDA
30/100
RADIOGENIX SYSTEM
technetium tc-99m sodium pertechnetate generator
Peak
NorthStar Medical TechnologiesNorthStar Medical Technologies
INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC · SOLUTION
2018
NDA
30/100
RANEXA
ranolazine
LOE Approaching
MenariniMenarini
ORAL · TABLET, EXTENDED RELEASE
2006
NDA
30/100
RAPAFLO
silodosin
LOE Approaching
AbbVieAbbVie
ORAL · CAPSULE
the signssymptoms of benign prostatic hyperplasia (BPH) [ see CLINICAL STUDIES ( ) ]+2
2008
NDA
30/100
RAPAMUNE
sirolimus
LOE Approaching
PfizerPfizer
ORAL · TABLET
2000
NDA
30/100
RAPAMUNE
sirolimus
LOE Approaching
PfizerPfizer
ORAL · SOLUTION
1999
NDA
30/100
RAPLON
rapacuronium bromide
LOE Approaching
M&
Merck & Co.
INJECTION · INJECTABLE
1999
NDA
30/100
RAVOCAINE AND NOVOCAIN W/ LEVOPHED
norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1952
NDA
30/100
← PreviousPage 150 of 277Next →